With millions of patients on GLP-1 inhibitors, doctors began noticing side benefits
Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control
Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, et al
Safety was assessed in all patients who received at least one dose of the study drug
However, NDI1 expression led to a reduced respiratory exchange ratio (RER) during the dark/active period, indicating a shift towards lipid metabolism (Fig
When combined with medicines such as metformin or insulin, there is a theoretical risk of hypoglycaemia (low blood sugar), and close monitoring would be required